Doctor Ho Sik Shin
Kosin University School of Medicine, Busan (Korea (Republic of))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease
Event: ESC Congress 2024
Topic: Oral Anticoagulation
Session: Clinical decision-making about oral anticoagulant therapy in atrial fibrillation
